Small Grants for Lung Tissue Research (R03)
The summary for the Small Grants for Lung Tissue Research (R03) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Small Grants for Lung Tissue Research (R03): -Purpose. This funding opportunity announcement (FOA) solicits research grant applications from applicant organizations that propose to conduct tissue-based research on interstitial fibrotic lung disease and/or COPD (chronic obstructive pulmonary disease). Supported projects will be required to utilize lung biospecimens and data collected by the Lung Tissue Research Consortium (LTRC). The goal of this initiative is to promote tissue-based research on COPD and interstitial fibrotic lung conditions, including studies to establish proof-of-concept in humans for novel mechanisms of pathogenesis. -Mechanism of Support. This FOA will utilize the NIH Small Grant (R03) award mechanism. -Funds Available and Anticipated Number of Awards. The NHLBI intends to commit approximately $1 million in FY 2008 to fund approximately 12 new grants and $1 million in FY 2009 to fund approximately 12 additional grants. Awards issued under this FOA are contingent upon the availability of funds, the submission of a sufficient number of meritorious applications, and the availability of adequate biospecimens and data from the LTRC.
Federal Grant Title: | Small Grants for Lung Tissue Research (R03) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-HL-08-008 |
Type of Funding: | Grant |
CFDA Numbers: | 93.838 |
CFDA Descriptions: | Lung Diseases Research |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Oct 17, 2008 |
Posted Date: | Feb 21, 2008 |
Creation Date: | Feb 21, 2008 |
Archive Date: | Nov 17, 2008 |
Total Program Funding: | $2,000,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification) County governments Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Private institutions of higher education Public and State controlled institutions of higher education City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Special district governments State governments
- Additional Information on Eligibility
- Foreign institutions are not eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
- • Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
- • Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...
- • Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
- • Lung Response to Inhaled Highly Toxic Chemicals
- • Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)